Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;42(10):1032-1035.
doi: 10.1002/cac2.12336. Epub 2022 Jul 19.

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach

Affiliations

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach

Mengxuan Zhu et al. Cancer Commun (Lond). 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Genomic profiling for HAS patients and validation of MUC19 as a critical gene for HAS development. (A) The mutation and CNV landscape of 40 patients. (B) The heatmap of CNV in the HAS. (C) Illustration of one case with CNV in chr19q12. (D) The TMB in four groups (our cohort, STAD, HCC, CRC) were compared. (E) The TMB in the subgroups of our cohort. (F) High degree of TMB was associated with better OS in HAS samples. (G) Western blot demonstrating levels of AFP in gastric cancer cells. Compared with cells transfected with control vector, the cells transfected with MUC19 overexpression lentivirus had higher AFP expression. (H) Representative immunohistochemical staining images show the expression of AFP and MUC19 in HAS tumors (upper); scale bar represents 50 μm; the correlation between immunohistochemistry staining intensity for AFP and MUC19 in HAS patients from the validation cohort (bottom). (I) Statistic analysis of invasion assay for GC cells with different MUC19 expressions. (J) Subcutaneous xenograft tumor model was established by injection of MUC19 overexpression (MUC19) or control HGC27 cells (Control). The photography of xenograft tumors after 4 weeks subcutaneous implantation of cells. (K, L) The xenograft tumor weight (K) and volume (L) were measured. (M) Subcellular localization of β‐catenin was assessed by immunofluorescence staining. Data are presented as means ± SEM. * P < 0.05, *** P < 0.005, ns, not significant.

References

    1. Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP‐producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer. 1985;56(4):840–8. - PubMed
    1. Choi W‐K, Cho D‐H, Yim C‐Y, Lee N‐R. Primary hepatoid carcinoma of the ovary: A case report and review of the literature. Medicine. 2020;99(19):e20051. - PMC - PubMed
    1. Xia R, Zhou Y, Wang Y, Yuan J, Ma X. Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments. Front Oncol. 2021;11:633916. - PMC - PubMed
    1. Liu X, Cheng Y, Sheng W, Lu H, Xu X, Xu Y, et al. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;34(10):1465–71. - PubMed
    1. Lu J, Ding Y, Chen Y, Jiang J, Chen Y, Huang Y, et al. Whole‐exome sequencing of alpha‐fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets. Nat Commun. 2021;12(1):3946. - PMC - PubMed

Publication types